Navigation Links
AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
Date:11/15/2012

IRVINE, Calif., Nov. 15, 2012 /PRNewswire/ -- AtheroNova Inc. (OTCBB: AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and to improve lipid profiles in humans, today announced that it has received a Notice of Issuance for its patent application for Dissolution of Arterial Plaque.  This patent issuance is the first major step in the development of the Company's intellectual property involving lipid modulation and reduction.  This issuance culminates a major effort by the Company and its patent counsel in pursuit of a patent covering the use of hyodeoxycholic acid for atherosclerotic plaque lesions. 

"This patent issuance is a tremendous milestone for the Company," said AtheroNova CEO Thomas W. Gardner.  "We are very confident that this patent will support our development project for AHRO-001 as we move toward the next phase of entering human clinical trials.  The Company's partner, OOO CardioNova, has completed a similar intellectual property filing on behalf of AtheroNova in the Eurasian markets and they expect action on these filings to be moving forward in the near future."

About AHRO-001

AHRO-001 is AtheroNova's first novel application for the treatment and prevention of atherosclerosis. Atherosclerotic plaque is the primary, underlying cause of heart disease and stroke in industrialized countries. AHRO-001 uses certain pharmacological compounds to regress atherosclerotic plaque deposits through a process known as delipidization. Delipidization dissolves plaques in artery walls, which are then removed by natural body processes. AtheroNova is developing, and seeks to eventually market AHRO-001, a product that has the potential to become a new standard of care for patients prone to atherosclerotic plaque accumulation.

About AtheroNova

AtheroNova Inc., through its wholly-owned subsidiary, AtheroNova Operations, Inc., is a biotechnolog
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. AtheroNova Names New Director
2. AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
3. AtheroNova Releases 2011 Financial Results
4. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
5. AtheroNova Announces a New Board Member
6. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
7. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
8. Ceres Receives $3.5 million from USAID for Trait Stacks
9. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
10. Hertz Fellow, Grant I. Gillary, Receives Hertz Foundation-George Lerman Fellowship
11. Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... 20, 2015 Veracyte, Inc . ... demonstrating the ability of the company,s molecular classifier ... other interstitial lung diseases (ILDs) using samples obtained ... to help thousands of patients avoid invasive, risky ... diagnosis – a frequent challenge for physicians and ...
(Date:5/20/2015)... , May 19, 2015 Research and Markets ... the "Global Cell Therapy Market Outlook 2020 " ... cell therapy in tissue and regenerative medicine is expected ... other options which could help in the growth of ... segment but they are unable to form new tissue ...
(Date:5/20/2015)... -- Health eCareers, the healthcare industry,s online career hub, ... looking for the flexibility of short-term assignments through ... tool dedicated exclusively to temporary and shift work ... employers to quickly find and hire experienced professionals ... other temporary positions, eliminating the time and resources ...
(Date:5/20/2015)... , May 20, 2015  Haemonetics Corporation (NYSE: ... President & CEO, will present at The Jefferies 2015 ... on June 1 st , 2015 at 8:30am ... Mr. Concannon,s presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
Breaking Biology Technology:Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
... March 8, 2011 Leading events organiser UBM Live ... ., today announced details of the anticipated content and new ... a leading International pharmaceutical event, being held from 18-20 April, ... full line-up of events surrounding CPhI Japan includes P-MEC Japan, ...
... ALCLS), the genome engineering specialist, and Etablissement Francais du ... France, announce that StemRed, an ambitious collaborative program to ... (iPS cells) has started on March 1. ... Curie University (UPMC), Bertin Technologies and CECS (Centre d,Etude ...
... In addition to reliable high efficiency transfection reagents, Mirus ... of the Reagent Agent(SM) - a new online tool ... any nucleic acid into any cell type, including hard-to-transfect ... on extensive in-house transfection and electroporation data, customer feedback, ...
Cached Biology Technology:UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 2UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 3UBM Announces Content for 10th Annual Japanese Pharma & Bio Events 4Cellectis and the Etablissement Francais du Sang Launch StemRed, a Program to Produce Red Blood Cells From Stem Cells 2Reagent Agent(SM) Transfection Cell Line Database From The Transfection Experts 2
(Date:5/21/2015)... 2015 According to a ... (Hardware, Software, Services), by Applications (Surveillance (Airborne, Maritime, ... End-Users (Military & Defense & Commercial) - Global ... Market is expected to grow from $7252.0 Million ... a Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
(Date:5/19/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... similar situations change as they age, according to a ... brain scanning, eye-tracking and behavioral measures to understand how ... preschool children and adults distinguish between damage done either ... done something wrong. Nonetheless, adults are much less likely ...
... studies were limited mostly to the movement of sick ... Professor of Systematic Zoology and Evolutionary Biology. To change ... study about the locomotion of healthy dogs in 2006 ... technical effort the scientists measured, documented and compared the ...
... NEW YORK, NY (May 26, 2011) The New ... dedicated to advancing cures for major diseases through stem ... University scientists, led by NYSCF Robertson Investigator Dr. ... humans into functional neurons. These neurons will ...
Cached Biology News:Changes in brain circuitry play role in moral sensitivity as people grow up 2Changes in brain circuitry play role in moral sensitivity as people grow up 3Dogs in motion 2Dogs in motion 3
... culture scale-up, these culture chambers produce cell ... 9 range and are useful alternatives ... • High mechanical • strength and structural ... shipping • Certified nonpyrogenic and sterilized by ...
BD BioCoat Laminin 150 mm Culture Dishes...
...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
Biology Products: